History
  • No items yet
midpage
Alliance for Natural Health U.S. v. Sebelius
775 F. Supp. 2d 114
D.D.C.
2011
Read the full case

Background

  • Dietary supplements regulated under DSHEA via FDCA; FDA CGMPs for dietary supplements finalized June 25, 2007 with staggered compliance dates through 2010.
  • Plaintiffs include Pearson, Shaw (scientists licensing formulas) and industry groups ANH USA and Coalition to End FDA Censorship.
  • Regulations at issue cover CGMP requirements for personnel, facilities, equipment, process controls, records, and quality systems in 21 C.F.R. Part 111.
  • Plaintiffs allege the GMPs exceed FDA authority by imposing standards not tied to analytical methodologies; also claim vagueness and APA violations.
  • Dispute centers on statutory interpretation of 21 U.S.C. § 342(g)(2): whether CGMPs must be based on current, generally available analytical methods.
  • Court posture includes standing analysis, then merits, with summary judgment posture for FDA.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether FDA CGMPs exceed statutory authority Plaintiffs contend §402(g)(2) limits to method-based standards FDA argues authority to regulate via general CGMP standards; not limited to methods GMA upheld; FDA interpretation proper
Whether §402(g)(2) requires current, generally available analytical methodology GMPs must be tethered to current analytical methods Regulations may address general GMP matters; not all must be method-based FDA interpretation sustained; not limited to method-based standards
Standing of Pearson/Shaw (injury-in-fact) Harm via licensees’ reduced royalties from GMP costs Individually named plaintiffs not directly regulated; connection via third parties Pearson and Shaw have standing; injury traceable and redressable
Vagueness under Fifth Amendment and APA Terms like adequate/suitable/qualified vague; invite arbitrary enforcement Regulations contain contextual specifics; reasonably definite for industry Not unconstitutionally vague; not arbitrary or capricious under APA
Chevron step one vs step two Statute unambiguous; FDA overstepped Statute permits FDA to model CGMPs on food regs; step-two upholds agency Chevron analysis supports FDA's interpretation at both steps

Key Cases Cited

  • Chevron U.S.A. Inc. v. Natural Resources Defense Council, Inc., 467 U.S. 837 (U.S. 1984) (establishes two-step framework for statutory deference to agency interpretations)
  • Motor Vehicle Mfrs. Ass'n of U.S. v. State Farm Mutual Auto. Ins. Co., 463 U.S. 29 (U.S. 1983) (requires rational connection between facts and agency choice; arbitrary/conduct invalid)
  • United States v. Cartons of
    • an Article of Food, 987 F.2d 33 (1st Cir. 1993) (context for FDA regulation of foods prior to DSHEA)
  • Rancho Viejo, LLC v. Norton, 323 F.3d 1062 (D.C.Cir. 2003) (no-set-of-cacts vagueness standard for facial challenge; upheld regulation)
  • National Wrestling Coaches Ass'n v. Dept. of Educ., 366 F.3d 930 (D.C.Cir. 2004) (standing and causation in regulatory challenges)
Read the full case

Case Details

Case Name: Alliance for Natural Health U.S. v. Sebelius
Court Name: District Court, District of Columbia
Date Published: Apr 6, 2011
Citation: 775 F. Supp. 2d 114
Docket Number: Civil Action 09-1523 (BAH)
Court Abbreviation: D.D.C.